Andrew S Bomback Selected Research

Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)

1/2022	Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
1/2020	Treatment-resistant nephrotic syndrome in dense deposit disease: complement-mediated glomerular capillary wall injury?
1/2019	Kidney Transplantation in C3 Glomerulopathy: A Case Series.
9/2016	Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways.
3/2014	Anti-complement therapy for glomerular diseases.
2/2014	Toward a working definition of C3 glomerulopathy by immunofluorescence.
1/2014	Eculizumab in the treatment of membranoproliferative glomerulonephritis.
8/2012	C3 glomerulopathy: what's in a name?
7/2012	Pathology after eculizumab in dense deposit disease and C3 GN.
5/2012	Eculizumab for dense deposit disease and C3 glomerulonephritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew S Bomback Research Topics

Disease

16	Proteinuria 03/2022 - 02/2008
15	Chronic Renal Insufficiency 10/2017 - 02/2008
13	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 12/2009
11	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 03/2011
11	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2021 - 04/2009
11	Glomerulonephritis 01/2021 - 03/2011
11	Hypertension (High Blood Pressure) 01/2021 - 08/2011
10	Lupus Nephritis 01/2021 - 12/2010
8	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 03/2011
7	Heart Failure 01/2021 - 10/2009
6	Kidney Diseases (Kidney Disease) 01/2022 - 02/2008
5	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 03/2011
5	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 04/2011
5	IGA Glomerulonephritis (IGA Nephropathy) 01/2020 - 03/2011
5	Hyperkalemia 01/2016 - 02/2008
5	Albuminuria 07/2013 - 11/2009
4	Inflammation (Inflammations) 01/2021 - 01/2009
3	Neoplasms (Cancer) 11/2021 - 03/2012
3	Diabetic Nephropathies (Diabetic Nephropathy) 04/2021 - 09/2012
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2019 - 03/2011
3	Anemia 05/2014 - 03/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2013 - 02/2008
3	Obesity 03/2010 - 11/2008
2	Paraproteinemias (Monoclonal Gammopathy) 11/2021 - 07/2014
2	Infections 11/2021 - 03/2011
2	COVID-19 11/2021 - 09/2020
2	Renal Insufficiency (Renal Failure) 01/2021 - 01/2020
2	Hematuria 11/2020 - 01/2020
2	Necrosis 07/2015 - 07/2009
2	Fibrosis (Cirrhosis) 03/2015 - 01/2009
2	Atypical Hemolytic Uremic Syndrome 03/2014 - 01/2014
2	Diabetes Mellitus 07/2013 - 09/2012
2	Weight Gain 01/2012 - 12/2009
1	Hyponatremia 07/2021
1	Polydipsia 07/2021
1	Hypovolemia 07/2021
1	Dehydration (Water Stress) 07/2021
1	Headache (Headaches) 07/2021
1	Vasculitis (Vasculitides) 05/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 05/2021
1	Microscopic Polyangiitis 05/2021
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 05/2021

Drug/Important Bio-Agent (IBA)

14	CreatinineIBA 01/2021 - 11/2009
12	AldosteroneIBA 10/2017 - 02/2008
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2017 - 02/2008
6	Angiotensin Receptor AntagonistsIBA 10/2017 - 02/2008
6	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 05/2014 - 02/2008
5	Immunoglobulin G (IgG)IBA 01/2021 - 06/2012
5	SteroidsIBA 01/2020 - 03/2011
5	eculizumab FDA Link 01/2020 - 05/2012
4	Rituximab (Mabthera)FDA Link 11/2021 - 04/2009
4	SaltsIBA 07/2021 - 01/2009
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2021 - 04/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 06/2012
4	Complement System Proteins (Complement)IBA 01/2020 - 01/2014
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 12/2010
4	Immunoglobulin A (IgA)IBA 01/2019 - 03/2011
4	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2013 - 03/2011
4	Parathyroid Hormone (Parathormone)IBA 07/2013 - 03/2010
4	AlbuminsIBA 04/2013 - 06/2007
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 08/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 12/2010
3	Mineralocorticoid Receptor AntagonistsIBA 04/2021 - 08/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2020 - 03/2015
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2016 - 02/2009
3	CalciumIBA 07/2013 - 03/2010
3	Phosphorus (Red Phosphorus)IBA 07/2013 - 03/2010
3	Hemoglobins (Hemoglobin)IBA 07/2013 - 03/2010
2	GlucocorticoidsIBA 11/2021 - 01/2020
2	Calcineurin InhibitorsIBA 01/2020 - 01/2018
2	Dichlorodiphenyldichloroethane (DDD)IBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Alkylating AgentsIBA 01/2018 - 08/2011
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2018 - 05/2012
2	AcidsIBA 01/2016 - 04/2015
2	sodium phosphate (trisodium phosphate)FDA LinkGeneric 01/2016 - 09/2014
2	ElectrolytesIBA 01/2016 - 04/2015
2	Phosphates (Orthophosphate)IBA 01/2016 - 09/2014
2	SodiumIBA 03/2015 - 07/2009
2	Antihypertensive Agents (Antihypertensives)IBA 09/2014 - 07/2014
2	Immunoglobulin M (IgM)IBA 02/2014 - 06/2012
1	oxidized low density lipoproteinIBA 03/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Phospholipase A2 ReceptorsIBA 11/2021
1	AntibodiesIBA 11/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2021
1	Arginine Vasopressin (Argipressin)IBA 07/2021
1	Myeloblastin (Proteinase 3)IBA 05/2021
1	Peroxidase (Myeloperoxidase)IBA 05/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2021
1	ReninIBA 04/2021
1	AngiotensinsIBA 04/2021

Therapy/Procedure

29	Therapeutics 11/2021 - 02/2008
4	Kidney Transplantation 01/2020 - 09/2010
2	Glycemic Control 04/2021 - 09/2012
2	Precision Medicine 01/2018 - 01/2018
1	Blood Component Removal (Apheresis) 03/2022
1	Plasmapheresis 03/2022